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Abstract. Low density lipoprotein (LDL) and (3-very
low density lipoprotein (/3VLDL) are internalized by
the same receptor in mouse peritoneal macrophages
and yet their endocytic patterns differ; (3VLDL is tar-
geted to both widely distributed and perinuclear vesi-
cles, whereas LDL is targeted almost entirely to peri-
nuclear lysosomes. This endocytic divergence may
have important metabolic consequences since OVLDL
is catabolized slower than LDL and is a more potent
stimulator of aryl-CoA/cholesterol acyl transferase
(ACAT) than LDL. The goal of this study was to ex-
plore the determinants of (3VLDL responsible for its
pattern of endocytic targeting. Fluorescence micros-
copy experiments revealed that large, intestinally de-
rived, apoprotein (Apo) E-rich /3VLDL was targeted
mostly to widely distributed vesicles, whereas small,
hepatically derived OVLDL was targeted more cen-
trally (like LDL). Furthermore, the large /3VLDL had
a higher ACATstimulatory potential than the smaller
OVLDL. The basis for these differences was not due
to fundamental differences in the means of uptake;
L
NDs and receptors internalized by receptor-mediated
endocytosis may undergo a variety of cellular itin-
eraries, including targetingofboth ligand and recep-
torto lysosomes, recycling ofbothligand andreceptor tothe
cell surface, or targeting ofthe ligand to lysosomes and re-
ceptor to the cell surface after ligand-receptor uncoupling
in sorting endosomes (13). A major goal in this area of re-
search has been to elucidate ligand-receptor properties that
mayinfluencetheendocyticitinerary andthustheintracellu-
lar metabolism of individual ligands and their receptors.
Alongtheselines, severalgroups havereportedthatthecross-
linking ofspecific receptors by polyvalent antibody or mul-
tivalent ligands on gold particles can alter the endocytic
itinerary ofthese ligands and their receptors (1, 14, 26, 29,
32, 38).
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both large and small RVLDL were internalized by re-
ceptor-mediated endocytosis (i.e., not phagocytosis)
involving the interaction of Apo E of the ,8VLDL
with the macrophage LDL receptor. However, large
aVLDL was much more resistant to acid-mediated re-
lease from LDL receptors than small /3VLDL. Fur-
thermore, partial neutralization of the multiple Apo Es
on these particles by immunotitration resulted in a
more perinuclear endocytic pattern, a lower ACAT
stimulatory potential, and an increased sensitivity to
acid-mediated receptor release. These data are consis-
tent with the hypothesis that the interaction of the mul-
tivalent Apo Es of large (3VLDL with multiple macro-
phage LDL receptors leads to a diminished or retarded
release of the OVLDL from its receptor in the acidic
sorting endosome which, in turn, may lead to the
widely distributed endocytic pattern of large aVLDL.
These findings may represent a physiologically relevant
example of a previously described laboratory phenom-
enon whereby receptor cross-linking by multivalent li-
gands leads to a change in receptor targeting.
Research from our laboratories has revealed that two
differentlipoproteinligands forthe same receptor, the mac-
rophagelowdensity lipoprotein (LDL) receptor, havediver-
gent endocytic pathways in mouse peritoneal macrophages:
LDL is rapidly targeted to perinuclear lysosomes near the
center ofthecell, whereas asignificant portion oftheR-very
low density lipoprotein ((3VLDL) is found in more widely
distributed vesicles whose interiors are relatively electron
lucent whenviewed by EM (37). This finding hastwo poten-
tial areas of importance. Firstly, an understanding of the
1. Abbreviations used in thispaper: ACAT, acyl-CoA/cholesterol acyl trans-
ferase; Apo, apoprotein; CE, cholesteryl ester; Dil, 1,1'-dioctadecyl-
3,3,3',3'-tetramethyl-indocarbocyanine perchlorate; LDL, low density lipo-
protein; VLDL, very low density lipoprotein.mechanism ofthe endocytic divergence of these two ligands
may help elucidate ligand properties that are important in de-
termining endocytic itineraries. Secondly, the divergent en-
docytic targeting of LDL and #VLDL in macrophages may
have important physiological consequences related to their
intracellular metabolism. In particular, O-VLDL is degraded
more slowly and stimulates the intracellular cholesterol es-
terification enzyme acyl-CoA/cholesterol acyl transferase
(ACAT) more potently than LDL in these cells (37) . Since
macrophages which have accumulated large amounts of
ACAT-derived cholesteryl ester (CE) ("foam cells") are a
prominent feature of atherosclerotic lesions (8, 10, 34) and
since OVLDL is known to be an "atherogenic" lipoprotein
(25), our studies on the endocytosis of /3VLDL in macro-
phages may contribute to our understanding ofmechanisms
of atheroma foam cell formation.
The goal ofthe current study was to explore the properties
ofRVLDL particles that are responsible for their distinct en-
docytic pathway (and metabolism) in macrophages. The data
revealed that not all /3VLDL particles behaved similarly:
large apoprotein (Apo) E-rich, intestinally derived fl-VLDL
were targeted mostly to widely distributed vesicles, whereas
small, hepatically derived SVLDL were targeted more cen-
trally (like LDL). These endocytic differences were as-
sociated with an important metabolic difference as well:
largeaVLDL stimulated ACAT greater than small /3VLDL.
Several possible explanations for these endocytic (and
ACAT) differences were explored, and the data suggest that
binding of large ,QVLDL via multiple Apo E subunits to
macrophage LDL receptors, which probably leads to recep-
tor cross-linking, results in an alteration of the pattern of en-
docytosis and perhaps ACAT stimulation. Thus, these find-
ings may represent a physiologically important example of
the effects of ligand multivalency and receptor cross-linking
on ligand-receptor endocytic routing.
Materials andMethods
Cells
Peritoneal macrophages from unstimulated female ICR mice (25-35g.,
Harlan Sprague Dawley, Inc., Indianapolis, IN) were plated onto coverslip-
bottom dishes and preincubated for 2 d in DME/10% lipoprotein-deficient
serum (vol/vol) as previously described (37). In certain experiments, the
LDL receptor on the cells was partially down-regulated by adding to the
preincubation medium 5 pg/ml acetyl-LDL (11) plus 1 pg/ml ofthe ACAT
inhibitor, compound 58-035 (3-[decyldimethylsilyl]-N-[2-(4-methylphenyl)-1-
phenylethyl] propanamide) (31) (generously provided by Dr. John Heider,
Sandoz, Inc., East Hanover, NJ). All experiments were performed on
day 3.
Lipoproteins andProteins
LDL was prepared as previously described (37). d < 1.006 lipoproteins
from cholesterol-fed rabbits and cholesterol-fed dogs were prepared by
ultracentrifugation at d = 1.006 g/ml (17) . These d < 1.006 lipoproteins,
which contain mostly S-VLDL butalso some pre-flVLDL, will be referred
to as simply "O-VLDL:' Aggregated LDL was prepared by vigorously vor-
texing LDL for 30 s as described by Khoo et al. (18).
The lipoproteins were labeled with 1,1'-dioctaolecyl-3,3,3 ;3'-tetramethyl-
indocarbocyanine Perchlorate (DiI) (Molecular Probes Inc., Junction City,
OR) by the method of Pitas et al. (30) and with 1251 (IMS.30; carrier-free;
Amersham Corp., Arlington Heights, IL) using iodine monochloride as de-
scribed in detail previously (12). The lipoproteins were labeled with 3H-
labeled CE by transfer (via semipurified CE transfer protein) of 3H-CE
from 3H-CE-HDL donor (36).
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Canine ,BVLDL lipids and proteins were analyzed for lipid composition
(cholesterol, triglycerides, and phospholipid) by analysis on a Spectrum
high performance diagnostic system (Abbott Laboratories, Diagnostic Div.
Department, Abbott Park, IL) and for protein content by the method of
Lowry et al. (24). Negative-stain EM of the ,BVLDL was carried out as
described by Boyles et al. (4). Canine SVLDL was fractionated by gel
filtration chromatography on BioGel A-150m agarose beads (Bio-Rad
Laboratories, Richmond, CA) in saline-EDTA (0.15 M NaCl, 0.01%
EDTA) (9). Each fraction was analyzed by absorbance at 280 not and by
colorometric cholesterol assay (Boehringer Mannheim Diagnostics, Inc.,
Houston, TX) to determine peaks.
a2-Macroglobulin (a2M) was purified, converted to the receptor-
binding form, and conjugated to FITC as previously described (33).
Antibodies
Pblyclonal rabbit anti-bovine adrenal LDL receptor antibody was prepared
as described by Schneider et al. (35) and Beisiegel et al. (3). Monoclonal
antibodies against Apo B100 (4G3, IgG2.) and Apo E (1D7, IgGi) were
kindly provided by Drs. Ross Milne and Yves Marcel (Clinical Institute of
Montreal, Montreal, Canada) and were characterized previously (27, 28).
The polyclonal and monoclonal antibodies were purified by protein
A-Sepharose chromatography. As a control (i.e., irrelevant) antibody, we
used rabbit IgG against dinitrophenyl-BSA or mouse monoclonal IgG,
against clathrin heavy chain. Anti-Apo E (1I77) Fab fragments were made
by digesting the intact IgG with immobilized papain and then separating the
Fab fragments from Fc fragments and undigested IgG using animmobilized
protein A column (ImmunoPure Fab preparation kit, Pierce Chemical Co.,
Rockford, IL).
Video Intensification Fluorescence Microscopy
Cells were incubated, washed, formaldehyde fixed, and viewed by fluores-
cence microscopy as described previously (37) and as indicated in the in-
dividual figurelegends. Images were digitized (Gould-VicomIP9000image
processor, Vicom, Inc., Fremont, CA) and photographs were produced (Po-
laroid Freeze Frame, Polaroid Corp., Cambridge, MA).
Individual cells from double-labeled experiments (fluorescein-a2M and
Dil-labeled lipoproteins) were analyzed for overlap of fluorescent vesicles
as follows: autofluorescence and out-of-focus background fluorescence in
the digitized images were removed by applying a 32 x 32 pixel (5.5 x 5.5
/m) median filter to a digitized image, and subtracting the result from the
original image. Individual endocytic vesicles were detected as contiguous
groups of pixels with an intensity greater than a specified threshold. Pixels
not removed by background subtraction were eliminated by deleting from
a vesicle any pixel with an intensity <50% of the maximum intensity ofthe
vesicle. This procedure separates close but distinct vesicles while retaining
an accurate relative measure of intensity for each vesicle (6). Next, images
were aligned to correct for the small relative offset of the images resulting
from the use of different filter sets for fluorescein and Dil fluorescence. In
addition, a few cells failed to endocytose significant amounts of a2M . To
avoid underestimating the amount of overlapping vesicles, a2M-negative
cells were individually removed from both images in the double-label pair.
Finally, these pairs of processed images ofendosomes were used to deter-
mine whether individual endosomes contained both labeled ligands. If
<25 % of the pixels in a RVLDL-containing endosome overlapped with an
a2M-containing endosome, the endosome was considered to lack a2M.
The number and total intensity of nonoverlapping endosomes was deter-
mined, and expressed as a fraction ofthe total number or total intensity of
endosomes in an image. Several images were analyzed for each experimen-
tal condition, with each image containing 3-5 cells.
SDS-PAGE
,QVLDL fractions were dialyzed against 0.01% EDTA, lyophilized, delipi-
dated with chloroform/methanol, and resolubilized in SDS sample loading
buffer according to the method ofKing and Laemmli (19). The samples (10
kg) were electrophoresed under reducing conditions on a 5-20% gradient
SDS-polyacrylamide gel. The protein bands were stained with Coomassie
blue, and the wet gels were scanned on a densitometer (model GS300,
Hoefer Sci. Instrs., San Francisco, CA). Thedata were integrated using gel
scanner software (DataLab, St. Jude's Children's Hospital, Memphis, TN)
on an Apple computer. The molecular mass markers used were lysozyme
(14.3 kD), trypsin inhibitor (21.5 kD), carbonic anhydrase (30kD), ovalbu-
min (46 kD), BSA (69 kD), phosphorylase b (97 kD), and myosin (200kD) .
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.OtherAssays
1251-lipoprotein degradation and binding assays and whole cell ACAT as-
says were performed as previously described (37) . The cellular content of
lipoprotein-derived [3H]cholesterol was determined by TLC analysis of
cellular unesterified and esterified [3H]cholesterol as previously described
(37) . Protein was measured by the method of Lowry et al . (24) .
Results
Characterization andEndocytic Patterns ofCanine
(3-VLDLSubfractions
Research from our laboratories has recently demonstrated
that endocytosis ofrabbit /3VLDL bymouse peritoneal mac-
rophages resulted in a pattern of endocytosis distinct from
that of LDL ; the LDL was rapidly targeted to perinuclear
lysosomes whereas much of the rabbit aVLDL was targeted
to more widely distributed vesicles (37) . During some initial
experiments designed to elucidate the properties of /3VLDL
responsible for its distinctpattern of endocytic targeting, oc-
casional rabbit ,QVLDL preparations were noted to give a
more "mixed" pattern of endocytosis (i.e ., central plus
widely distributed) than the mostly widely distributed pat-
tern of other rabbit (3VLDL preparations . In further experi-
ments, (3-VLDL obtained from cholesterol-fed dogs was
found to consistently give a "mixed" pattern of endocytosis.
The double-label fluorescence micrographs shown in Fig . 1
compare the endocytic patterns of DiI-canine /3VLDL and
DiI-LDL with that of fluorescein-012M, which, like LDL, is
rapidly targeted to central lysosomes (see reference 37 and
below) and thus can serve as a reference for comparison
of endocytic patterns . The comparison of the DiI-canine
aVLDL pattern (Fig . 1 A) with the fluorescein-a2M pattern
(Fig . 1 B) showed that the canine (3VLDL pattern contained
many central vesicles that overlapped with fluorescein-a2M
as well as some nonoverlapping, widely distributed vesicles ;
the phase photomicrograph of these cells is shown in Fig .
1 C. This comparison was in contrast to the comparison of
Df-LDL (Fig . 1 D) with fluorescein-a2M (Fig . 1 E), where
the overlap in fluorescence was almost complete. Thus, ca-
nine (3VLDL was targeted to both central lysosomes and
more widely distributed vesicles inmouse peritoneal macro-
phages . This pattern of endocytosis was different from those
of LDL and a2M, which were almost completely targeted
to central lysosomes, and from most preparations of rabbit
(3VLDL, which were targetedmuchmore to the widely dis-
tributed vesicles (37) .
The "mixed" endocytic pattern ofcanineaVLDL was fur-
ther explored with the idea that such studies might reveal
properties ofaVLDL which were important in its targeting
to the widely distributed vesicles. Along these lines, experi-
ments were designed to determine whether this heteroge-
neous pattern was related to another area in which canine
aVLDL heterogeneity had been demonstrated: particle size
and origin . Cholesterol-fed dogs give rise to large, intesti-
nally derived (3VLDL particles as well as smaller, hepati-
cally derived particles (9) . Therefore, DiI-labeled canine
OVLDL was size fractionated using gel filtration chroma-
tography (BioGel A-150m), and the fractions were examined
for their endocytic patterns and ACATstimulatory potential .
Figure 2 . Gel filtration chromatography of Di1-labeled canine (3VLDL . (Left) DiMabeled canine OVLDL was loaded onto a 3.2 x 90-cm
BioGel A-150m gel filtration column, and 4.5-ml fractions were collected . The cholesterol content of each fraction was assayed using a
standard colorimetric assay. The fractions were pooled as indicated (A-F) . (Right) Negative-stain electron microscopy of canine fVLDL
size subfractionsA-F . Fx, fraction . Bar, 1,000 run .
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1550Fig. 2 shows the gel filtration profile of DiI-labeled canine
/3VLDL. There was a small peak of cholesterol-containing
material in the void volume (fraction A) and a larger peak
of material in the included volume (fractions D-F). Frac-
tions in between these two peaks (B and C) were also har-
vested as indicated in the figure. Fig. 2 shows negative-stain
electron micrographs ofeach of the six fractions (A-F) from
the gel filtration chromatography. Fractions A and B had the
characteristic appearance of chylomicron remnant particles
(white eccentric core and gray periphery), with the particles
in fraction A measuring -350-600 nm in diameter and
those in fraction B measuring -230-400 nm. Fractions C-F
did not have the remnantlike appearance and measured
-150-230 nm (C), -100-150 nm (D), -75-100 rim (E),
and -50-75 nm (F) .
Further characterization of the canine /3VLDL subfrac-
tions is shown in Table I. Compared to the smaller SVLDL,
the larger particles have a higher triglyceride content and
lower protein, cholesterol, and phospholipid contents. In ad-
dition, Coomassie-stained 5-20% gradient SDS-PAGE of
canine holo-/3VLDL (which consists mostly of smaller
(3VLDL, see above) and pooled fractions D-F revealed that
these fractions were enriched in Apo B-100 (data not
shown), consistent with the hepatic origin ofsmall SVLDL.
In contrast, the Apo B bands offractions A-C were enriched
in Apo B-48, consistent with their intestinal origin. Lastly,
since eachfVLDLparticle contains one copy ofApo B, one
can obtain an estimate of the relative Apo E content per
,QVLDL particleby calculating for each fraction the densito-
metric ratio of the Apo E band to the Apo B bands (cor-
recting for the smaller size of Apo B-48 vs. Apo B-100).
The results ofthis analysis are shown in Table I; note that the
analysis estimates the relative Apo E/Apo B ratios among the
fractions, not the absolute molar ratio of each fraction. The
data corroborate previous data (9) and show that the frac-
tions of large QVLDL (A-C) have a -4-9-fold higher Apo
E/Apo B ratio (i.e., Apo E/particle ratio) than the fractions
of smaller OVLDL (D-F).
The endocytic patterns of the six canine DiI-,8VLDL
fractions in mouse peritoneal macrophages are shown in Fig.
3. In this experiment, each of the fractions was incubated
with the macrophages for 5 min and then chased in the ab-
senceoflipoproteins for 5 min. The cellswere then fixed and
viewed by fluorescence microscopy (Fig. 3, A-F) and phase-
contrast microscopy (Fig. 3, A'-F'). The micrographs show
a marked difference in pattern between the biggest fractions
(A and B) and the smallest fractions (E and F): fractions A
and B gave a preponderance of widely distributed vesicles
(reminiscent of the rabbit OVLDL patterns shown in refer-
ence 37) whereas fractions E and F were mostly central, like
the patterns for LDL or a2M (refer to Fig. 1) . Fractions C
and D appeared to give patterns that were "mixed" or in-
termediate between those of the largest and smallest frac-
tions. Thus, the endocytic patterns of large and small canine
(3VLDL subfractions differed, and this heterogeneity was
most likely the basis for the "mixed" pattern of endocytosis
seen with canine holo-(iVLDL.
To quantify these fluorescence microscopy data using a
larger number of cells, a double-label study was conducted
in which the endocytic patterns of each of the different
,BVLDL subfractions were directly compared (that is, in the
same cell) to the endocytic pattern of fluorescein-a2M,
Tabas et al. Lipoprotein Endocytosis in Macrophages
Table I. Percent Composition by Weight and
Apo E/Apo B Ratios ofCanine Holo-/3-VLDL and
O-VLDL Subfractions
Holo-O-VLDL from cholesterol-fed dogs was isolated, fractionated on BioGel
A-150m (see Fig. 2), and analyzed for protein and lipid composition (by
weight) as described in Materials and Methods. Fx, fraction; Prot, protein;
Choi, cholesterol; TG, triglyceride; PL, phospholipid.
For the densitometric Apo E/Apo B ratios, canine holo-o-VLDL and frac-
tions A-C, and pooled fractions D-Fwere subjected to 5-20% SDS-PAGE un-
der reducing conditions and then stained with Coomassie blue and analyzed by
densitometry as decribed in detail in Materials and Methods. Thedensitometric
Apo E/Apo B ratio for each ofthe fractions (as an estimate of the relative Apo
E//3-VLDL particle ratios) was calculated as follows: densitometry value of
Apo E - (densitometry value ofApo B-100 + 2 x densitometry value of Apo
B-08). (The densitometry value ofApo B-48, which is approximately one-half
the size ofApo B-100, was multiplied by two to correct for the likelihood that,
per molecule, its staining intensity would be about halfthat ofApo B-100.) The
actual densitometry values (x 10-°) of holo-O-VLDL and fractions A-C, and
D-F, respectively, were as follows: Apo E = 21 .5, 40.0, 44.4, 35.3, 19.7;
Apo B-100 = 21 .7, 3.1, 1 .5, 2.1, 25.4; and Apo B-48 (before multiplying by
two) = 8.4, 5.2, 2.4, 3.2, 0.
* Data from pooled fractions D, E, and F.
which, as shown above (see Fig. 1), gives a central pattern
of fluorescence like LDL. Macrophages were incubated
(5-min pulse/5-min chase) with each of the Dil-labeled ca-
nine aVLDL subfractions plus fluorescein-a2M and then
viewed by fluorescence microscopy. The images (each con-
taining several cells) were then analyzed by digital image
processing to determine the percentageofDil (i.e., (3VLDL)
fluorescence intensity or vesicle number that was nonover-
lapping in each cell. Thus, a greater degree of nonoverlap
with fluorescein-a2M would be a quantitative measure of
the more widely distributed pattern of fluorescence. The
data, displayed in Fig. 4, show that fractions A and B had
a greater degree of nonoverlap with fluorescein-a2M than
fractions D and F or LDL, whether basedupon fluorescence
vesicle number (hatched bars) or fluorescent intensity (open
bars). When this analysis was applied to another experiment
using a different preparation of DiI-labeled canine (3VLDL
subfractions, similar results were obtained. Thus, the quan-
titative analysis of fluorescent patterns in multiple images
corroborated the impressions gained from viewing the fluo-
rescence micrographs in Fig. 3 and demonstrated that canine
O-VLDL large subfractions gave a more widely distributed
pattern of endocytosis in macrophages than /3VLDL small
subfractions.
ACAT-stimulatory Pbtential ofCanine
O-VLDL Subfractions
Based upon our previous study comparing the endocytic pat-
tems and ACATstimulatory potentials of rabbit fVLDLand
human LDL, a causal relationship between the widely dis-
tributed endocytic pattern of rabbit OVLDL and its high
ACATstimulatory potential was hypothesized (37) . Given
1551
O-VLDL
fraction Prot
% Composition
Chol TG PL
Densitometric
Apo E/Apo B
ratio
Holo 13.2 45.6 21.1 20.1 0.6
Fx A 2.5 38.7 43.2 15.6 3 .0
Fx B 5.4 51 .2 27.7 15.7 7 .1
Fx C 6.8 42.9 30.9 19.4 4.2
Rx D 8.8 42.9 28.0 20.3
Fx E 9.4 49.6 14.4 26.6 0.7*
Fx F 13.8 50.2 12.4 23.6Figure 3 . Fluorescence and phase microscopy of macrophages incubated with Dil-labeled canine RVLDL size subfractions . Di1-labeled
OVLDL subfractions (fractionA[10 ug/ml], fraction B [15 ug/ml], and fractions C-F [25 ug/ml]) from the gel filtration chromatography
shown in Fig. 2 were incubated with macrophages for 5 min and then chased in the absence of lipoproteins for 5 min . The cells were
fixed and viewed by fluorescence and phase microscopy. A refers to macrophages incubated with Di1-labeled fraction A, B to fraction
B, etc; A', B', etc. refer to the respective phase images ofthemacrophages incubated with each of the /3VLDL subfractions . Bars, 10 Wm .Tabas et al . Lipoprotein Endocytosis in Macrophages
￿
1553'a '5
0 0
`y a 0 0
U
O
Z N
0)
C C
N N
U U
N Vi
H
The Joumal of Cell Biology, Volume 115, 1991
® Vesicle number
O Fluorescence intensity
A B C D F LDL
Figure 4 . Quantitative analysis of double-label fluorescent images
of macrophages incubated with DR-labeled RVLDL subfractions
(or Dil-LDL) plus fluorescenn-a2M . Macrophages were incubated
with Dil-labeled ,8VLDL subfractions as described in Fig. 5 (or
DiI-LDL [20 jig/ml]) plus fluorescenn-a2M (100,ug/ml) for 5 min
and then chased in the absence of lipoproteins for 5 min . The cells
were fixed and viewed by video intensification fluorescence micros-
copy. Two to four image sets (3-5 cells/image) were recorded on
videotape, digitized, and analyzed as described . The values shown
represent the percentage of nonoverlapping vesicle number and in-
tensity averaged over three or four images, ±SD among the images.
A refers to data obtained from macrophages incubated with Dil-la-
beled fraction A, Bto fraction B, etc; LDL refers to data obtained
from cells incubated with Dil-LDL . Four fields were analyzed for
fraction A, two fields for fractions B and C, three fields for fraction
D, and four fields for fraction F and LDL . The total number ofen-
dosomes ranged from 279 for fraction C to 1,089 for fraction A.
the different endocytic patterns of canine aVLDL subfrac-
tions (see above), experiments were conducted to determine
ifthere was a correlation between the endocytic targeting and
ACATstimulatorypotential ofthese subfractions. Therefore,
1151-labeled canine SVLDL subfractions and canine holo-
aVLDL were incubated with macrophages for 6 h, the last
2 h of which included 1°C-oleate, and cellular cholesteryl
1'C-oleate was measured to determine ACAT activity (Fig .
5 A) . The data show that the large subfractions of ,QVLDL
(i.e., fractionsA and B) stimulatedACATmuch greater than
the smaller subfractions and holo-aVLDL . However, it was
necessary to determine howmuch ofthis difference could be
explained simply by increased cellular cholesterol delivery
by the large O3VLDLs. Therefore, cellular "5I_SVLDL
degradation was assayed (Fig . 5 B, diagonal hatched bars),
and these protein degradation values were converted into
cholesterol delivery values (Fig . 5 B, open bars)based upon
the cholesterol/protein ratios of each of the subfractions .
(This method of estimating ,BVLDL-cholesterol delivery to
cells has been validated in separate experiments by direct
measurements of cholesterol delivery using 3H-CE-labeled
,8VLDL [X15,X., and I . Tabas, unpublished data]) . The data
show that although the larger subfractions did, in fact, de-
liver more cholesterol to the cells, this increased delivery
could not fully account for the increased ACAT differences .
This point is directly illustrated in Fig . 5 C, where the values
are expressed as an "ACAT activity/cholesterol delivery ra-
tio" to correct ACAT activity differences for differences in
cellular cholesterol delivery . The data clearly show that the
larger (3VLDL subfractions have a significantly greater
ACATstimulatory potential than the smaller subfractions .
This profile is very similar in appearance to the profile of the
quantitative endocytic data forthe subfractions shown in Fig .
Figure 5 . Degradation, estimated cholesterol delivery, and whole
cell ACAT activity in macrophages incubated with 1151-labeled
,13VLDL subfractions and holo-OVLDL . DiI-labeled /3VLDL
subfractions and holo-oVLDL (10 ug/nll) were labeled with 1151
and incubated with macrophages for 6 h . During the last 2 h ofthe
incubation, 1'C-oleate was added to the media (final concentration
= 10 mM) . The cells were then assayed for 14C-cholesteryl ester
content (ACAT activity) (A) and the medium was assayed forTCA
soluble 1251-cpm (lipoprotein degradation) (B, diagonal-hatched
bars) . From the protein degradation data and the cholesterol/pro-
tein ratio of each fraction, lipoprotein-cholesterol delivery to the
cell was calculated (B, open bars) . The data shown in C, which
were calculated from the data shown inA and B, are expressed as
the ratio (x10) ofACAT activity (nmol/mg cell protein per h) to
lipoprotein-cholesterol delivery (ug/mg per 6 h) . Values are means
f SEM (n = 3) .
4 . Thus, with canine /iVLDL subfractions, as with rabbit
(3VLDL vs . LDL, there was a correlation between a widely
distributed endocytic pattern and a relatively high ACAT
stimulatory potential .
Mechanisms ofInternalization
ofCanineSVLDL Subfractions byMouse
PeritonealMacrophages
Given the distinct endocytic pathway and the large size of
fraction A canine fVLDL and the fact that fraction A
O-VLDL constitutes only a small portion of holo-canine
,13VLDL (see Fig . 2), it was important to determine whether
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Figure 6. Effect of cytochalasin B on the degradation of 1251-la-
beledaVLDL subfractions, LDL, and aggregatedLDL. '251-labeled
largecanine aVLDL (fraction A), small canine SVLDL (fraction
F), LDL, and aggregated LDL (10 jig/ml) were incubated with
macrophages for 8 hin the absenceor presence oftheindicated con-
centrations of cytochalasin B, and 1251-lipoprotein degradation was
assayed. The data are expressed as percent degradation by cells in
the absence of cytochalasin B (3.2 jug/mg cell protein for fraction
A OVLDL, 2.4 for fraction F OVLDL, 1.5 for LDL, and 8.9 for
aggregated LDL) .
the mechanism of uptake by macrophages of Fx A (large)
(3VLDL was similar to that reported for canine holo-
(3VLDL, i.e., receptor-mediated endocytosis via interaction
ofOVLDL Apo E molecules with the macrophage's LDL re-
ceptor (2, 7, 15, 22). Fluorescence microscopy experiments
revealed that both a monoclonal antibody against the recep-
tor-bindingregionofApo Eand a polyclonal antibody against
the ligand-binding region of the LDL receptor each blocked
macrophage uptake of the large, as well as small, a-VLDL
particles (data not shown). In contrast, a monoclonal anti-
body against the receptor-binding region of Apo B100 did
not block uptake of the large, or small, S-VLDL (data not
shown). These data indicated that large (3VLDL, like small
fVLDL and holo-OVLDL (2, 7, 15, 22), are internalized
by macrophages via interaction of the Apo E molecules of
the SVLDL with the macrophage LDL receptor.
The next goal was to determine if the large fraction A
particles were internalized by a phagocytic mechanism. In
macrophages, phagocytosis is much more susceptible than
endocytosis to inhibition by the cytoskeletal inhibitor, cyto-
chalasin B (18, 20). Therefore, the uptake and degradation
of
X251-labeled large (3VLDL, small /3VLDL, LDL, and ag-
gregated LDL in mouse peritoneal macrophages, in the ab-
sence or presence of cytochalasin B, was measured (Fig. 6) .
The degradation of 1251-aggregated LDL, which consists of
complexes much larger in size than large /3VLDLand which
is known to be internalized by macrophages via a phagocytic
mechanism (18), was, as expected, inhibited by cytochalasin
B (Fig. 6, A) . In contrast, large #3VLDL (Fig. 6,,&), as well
as small OVLDL (9) and LDL (0), demonstrated relative
resistance to the inhibitory effects of cytochalasin B. Thus,
by this functional definition of phagocytosis, large OVLDL
particles are not internalized by macrophages via a phago-
cytic mechanism.
The Effect ofPartial Antibody-mediated
Neutralization ofApo E on the Endocytic Targeting
andACAT-stimulatory Fbiential ofLarge O-VLDL
A prominent, distinguishing characteristic of large ,QVLDL
molecules is that they contain more copies of Apo E per par-
ticle than small ,BVLDL (see above, Table 1, and reference
9). Thus, the possible role of multivalent Apo E in the en-
docytic targeting and ACATstimulatory potential of large
OVLDL was explored. For this purpose, DiI-labeled large
(3VLDL was titrated with an amountofanti-Apo E antibody
that partially blocked cellular uptake, thereby decreasingthe
valency of functional Apo E molecules on the particle. This
antibody-treated /3VLDL was then compared with control
SVLDL (treated with irrelevant antibody) for endocytic tar-
geting and ACATstimulatory potential. For these experi-
ments, a preparation ofDiI-labeled rabbit OVLDL was used
which was similar in size, endocytic targeting, ACATstimu-
latory potential, and Apo E content to canine fraction A
S-VLDL. (DiI-labeled rabbit OVLDL was used because it
couldbe more intensely labeled with DiI than fraction A ca-
nine (3VLDL, and thus the endocytic pattern ofthis lipopro-
tein in the presence of partially blocking amounts of
anti-Apo E antibody could be better viewed.)
The endocytic targeting data is shown in Fig. 7. A and B
show a double-label study comparing the endocytic patterns
of fluorescein-a2M and DiI-labeled (3VLDL, respectively,
in the same field of cells. As expected, the SVLDL pattern
included numerous widely distributed vesicles that were ab-
sent in the central fluorescein-012M pattern. Fig. 7, C and
D, shows a similar double-label study comparing thepatterns
of fluorescein-a2M and partial anti-Apo E-treated DiI-
labeled /3VLDL, respectively. In contrast to the control
aVLDL pattern (above), the antibody-treated /3VLDL pat-
tern was noticeably more central (Fig. 7 B), and there was
much more overlap with the fluorescein-a2M pattern (Fig.
7 C) . (The patterns of the control and anti-Apo E-treated
/3VLDLs are of similar brightness since high concentrations
of ,QVLDL were used [50 jAg/ml], thus assuring receptor
saturation even with the anti-Apo E-treated /3VLDL.) To
prove that the antibody-treated SVLDL was internalized by
the LDL receptor, we showed that the uptake could be
blocked by preincubating cholesterol-loaded cells with anti-
LDL receptor antibody. The Fc receptor was not involved in
the uptake of anti-Apo E-treated SVLDL since identical
results were obtained using Fab fragments generated from
the 1171 antibody (using the quantitative methodology de-
scribed for Fig. 4, 55 f 4 % ofthe vesicles from control Dil-
labeled aVLDL images did not overlap with fluorescein-
a2M vesicles, whereas only 28 t 6% of the vesicles from
anti-Apo E Fab-treated DiT-labeled /3VLDL images were
nonoverlapping [means f SD, n = 7 images]). Thus, treat-
ment of large SVLDL with an amount of anti-Apo E anti-
body that probably resulted in a decrease in the valency of
functional Apo E molecules ofthe particles led to more cen-
tral targeting of the (3VLDL.
Based upon the ACAT hypothesis described above, the
possibility that this change to a more central pattern was as-
sociated with a decrease in the ACATstimulatory potential
of the antibody-treated QVLDL was investigated (Fig. 8).
Thus, macrophages were incubated with 5 ;&g/ml control or
10 wg/ml partial anti-Apo E-treated 'H-CE-labeled large
/3VLDL for 5 h in the presence of 14C-oleate. Lipid ex-
tracts of the cells were assayed for both unesterified and es-
terified ['H]cholesterol ((3VLDL-cholesterol in cells; open
bars) and for cholesteryl 14(`-oleate (ACATderived CE;
cross-hatched bars). (Under the conditions of this experi-
ment, <10% of the (3VLDL-cholesterol delivered to the
cells is excreted to the medium [our unpublished data]). The
1555Figure 7 . Effect of partial anti-Apo E treatment oflarge /3VLDL on its endocytic targeting in macrophages . In the double-label experiment
shown in A and B, macrophages were incubated (6-min pulse/4-min chase) with 50 Ag/ml Dil-labeled large rabbit aVLDL (preincubated
with 50,ug/ml of an control antibody) plus 100 pg/ml fluorescein-01 2M . The cells were then fixed and viewed for fluorescein (A) and DiI
(B) . In the experiment shown in C and D, a similar protocol was used except 50 ug/ml Dil-labeled /3VLDL was preincubated with 50
ug/ml antiApo E antibody before incubation (plus fluorescein-012M) with macrophages . The fluorescein (UN) pattern is shown in C and
the Dil (,QVLDL) pattern is shown in D. Bar, 10,um .
data show that partial antiApo E treatment of /iVLDL led
to a twofold decrease in ACATderived CE under conditions
in which the lipoprotein-cholesterol delivered to the cells
was similar. Thus, anti-Apo E treatment of large ,EVLDL
changed both the endocytic pattern and the ACATstimula-
tory potential of the lipoprotein, furthering the correlation
between a widely distributed endocytic pattern and a high
ACATstimulatory potential .
ThepH-dependent ReleaseofLarge andSmall Canine
S-VLDLfromMacrophage SurfaceLDLReceptors
The endocytic pathway forLDL, like that formanyotherendo-
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cytosed ligands, involvesan acid-dependent dissociationofli-
gand from receptor in the sorting endosome ; the ligand is
then targeted to lysosomes, and the receptor is targeted to
the plasma membrane via a recycling pathway (13) . Thus,
part of the basis for the different endocytic targeting of small
/3VLDL (to perinuclear lysosomes) and large /3VLDL (to
more widely distributed vesicles) might be a difference in
acid-mediated ligand-receptor dissociation for the two
(3VLDLs in the sorting endosome . For instance, if the large
(3VLDL were more resistant to acid-mediated ligand-recep-
tor dissociation, less of the /3VLDL would be released from
its receptor and delivered to perinuclear lysosomes . As an
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initial test of this idea, 'III-labeled fraction F (small) or A
(large) canine aVLDL was incubated with macrophages at
4°C for 3 h at pH 7.4. The cells were then washed, and in-
dividual monolayers were incubated at 4°C for 20 min in
buffered solutions ranging in pH from 7.0 to 5.0. Cell-associ-
ated and media '251 were measured to determine the percent
release of ligand from the cell surface receptors (Fig. 9 A).
The data clearly show a difference in the release of large and
small aVLDL's: small (3VLDL (Fx F; o) was progressively
released from cell surface receptors as the pH was lowered
from 7.0 to 5.0. Similar results were found with LDL (data
not shown) . In contrast, large /3VLDL (Fx A; 9) showed
a marked resistance to acid-mediated release from the re-
ceptors.
To further explore this idea, an experimentwas designed to
determine whether partial anti-Apo E treatment of /3VLDL,
which changes its endocytic targeting to a more central pat-
tem (see above and Fig. 7), resulted in an increase in the
acid-dependent release of the aVLDL from its receptor. As
shown in Fig. 9 B, '25x-labeled large rabbit ,QVLDL was
treated in the absence or presence of two concentrations of
anti-Apo E Fab (weight ratios of Fab to "'I-aVLDL pro-
tein = 5 :1 and 12.5:1, respectively). Macrophages were then
incubated at 4°C with the untreated and Fab-treated 'ZSI-a-
VLDLs, and then the cells were postincubated (at 4°C) in
pH 5.5 buffer ; the relative amounts of cell-associated and re-
leased '251-RVLDL were determined. The data show that
antiApo E Fab treatment of ,QVLDL resulted, in a dose-
dependent manner, in a greater release of '251-(3VLDL from
cell surface receptors at pH 5.5. Thus, a functional decrease
in (3VLDL-Apo E valency by partial anti-Apo E treatment
resulted in both a more central endocytic pattern (see Fig.
7) and an increase in acid-mediated release from cell surface
receptors (see Fig. 9 B) . These findings support the hypoth-
esis that multivalent Apo E on large OVLDL particles, per-
haps through receptor cross-linking, results in decreased
dissociation of the particles from their receptors in acidic
sorting endosomes, which, in turn, may contribute to their
targeting to widely distributed vesicles in mouse peritoneal
macrophages.
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In our previous study, rabbit /3VLDL and human LDL, de-
spite beinginternalized by the same receptor, were shown to
have divergent endocytic pathways in mouse peritoneal mac-
rophages (37). A major goal resulting from that study was
to determine the properties of aVLDL important in its
divergent pattern of endocytosis. The current study has ap-
proached this issue by first showing that the widely distrib-
uted pattern of endocytosis characteristic of rabbit OVLDL
was seen only with the large, intestinally derived subfraction of
canine ,BVLDL. (Subsequently, most ofour rabbit aVLDL
preparations were shown to be heavily enriched in Apo
E-rich, large ,QVLDL [our unpublished data], thus explain-
ing why these preparations of holo-aVLDL from rabbit
gave a mostly widely distributed pattern.) With this finding,
the specific properties of large /3VLDL, distinct from those
of small ,QVLDL, that might be responsible for the widely
distributed pattern of endocytosis could be investigated.
Since most of canine holo-,BVLDL is made up of small
SVLDL (Fig. 2), one possibility not ruled out by previous
studies with holo-/3VLDL from dogs was that large OVLDL
particles were internalized by a different receptor or different
mechanism from small (3VLDL. In particular, given the
very large size of the large (3VLDL particles, there was a
possibility that these particles were phagocytosed by the
macrophages. However, the cytochalasin B experiment (Fig.
6) showed that the uptake was relatively resistant to disrup-
tion ofthe actin cytoskeleton, thus indicating that uptake by
a classical phagocytosis mechanism was unlikely (18, 20) .
Furthermore, the uptake of the large particles, like that of
canine holo-,QVLDL (2, 7, 15, 22), was dependent upon
Apo E of the SVLDL interacting with the macrophage's
LDL receptor (see text). In particular, the fact that an LDL
receptor antibody blocked particle uptake and thiol ester-
cleaved a2-macroglobulin did not block uptake (data not
shown; see reference 16) indicated that the LDL receptor-
related protein/a2-macroglobulin receptor (23) was not in-
volved in the uptake of largeaVLDL. From these combined
data, we concluded that the divergence in endocytosis be-U
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Figure 9. The effect of SVLDL particle size and anti-Apo E Fab
treatment on the pH-dependent release of /3VLDL from macro-
phage cell surface receptors. In A, 1231-labeled fraction A (e) or
fraction F canine ,BVLDL (0) (4 ug/ml) was incubated with mac-
rophages at 4°C for 3 h in DME/25 mM Hepes (pH 7.4)/10%
lipoprotein-deficient serum. The cells were then washed with
PBS/0.2% BSA and incubated with 50 mM NaCI/5 % lipoprotein-
deficient serum containing 50 mM Tris-succinate (pH 5.0 or 5.5)
or 50 mM Tris-maleate (pH 6.0, 6.5, or 7.0) for 20 min at 4°C. Cell-
associated and media 1231-cpm were measured, and the data are
expressed as 1231-cpm in the medium as a percent of total (i.e.,
medium + cell-associated) 1231-cpm. In B, 10 pg/ml 1231-labeled
large rabbit OVLDL was incubated for 1 h at 37°C in the absence
or presence of50 or 125 pg/ml anti-Apo-E Fab (indicated, respec-
tively, as Ratio Fab:0 = 0:1, 5 :1, or 12.5 :1). The labeled SVLDLs
were subject to the same acid-release experiment described for A
except that only pH 7.0 and 5.5 buffers were used. The pH 5.5 per-
cent release data is shown. The total 1231-/3VLDL originally
bound to the cells before addition of buffer (i.e., buffer-released
plus cell-associated) was 115.8 f 5.4, 111.1 t 7.3, and 114.6 t 3.2
ng/mgcell protein for the threeFab:,Q ratios, respectively. The per-
cent releases at pH 7.0 for Fab:0 ratios of 0:1 and 12.5 :1 were,
respectively, 33.2 f 0.1% and 31.6 f 0.1% . When a nonimmune
Fab was used at a ratioof 12.5 :1, the values were the same as those
obtained in the absence of Fab (i.e., ratio 0:1). Values are means
t SEM (n = 3).
tween large vs. small RVLDL was not due to phagocytosis
of the large particles or binding to different receptors.
Another possibility to explain the endocytic divergence
was particle size itself. The diameter of large OVLDL parti-
cles (see Fig. 2, inset) is similar to or larger than the di-
ameters of coated pits and endocytic vesicles, and it is con-
ceivable that a vesicle loaded to capacity with one large
particle may undergo alternative routing due to changes in
the interaction or fusion ofthe vesicle with other cellular or-
ganelles. However, the finding that partial anti-Apo E treat-
ment of large (3VLDL resulted in the particles' being tar-
geted more centrally (see Fig. 7) demonstrates that large
particle size alone is not sufficientfor targeting to widely dis-
tributed vesicles.
A third possibility for the endocytic divergence is re-
lated to the greater number of Apo E molecules per large
(3VLDL (vs. smallaVLDL) that might result in differences
in aVLDL-receptor interactions. An important role for
multiple Apo E's is suggested by the data in Fig. 7, which
shows that functional depletion ofApo E molecules on large
/3VLDL by titration with anti-Apo E antibody leads to an al-
most total elimination oftargeting to widely distributed vesi-
cles. An attractive hypothesis relating Apo E and endocytic
targeting is that the multivalent Apo E on large (3VLDL
might lead to a greater degree of receptor cross-linking than
those on small (3VLDL, which, in turn, may be responsible
for the greater resistance ofthe largeaVLDLto acid-medi-
ated release from receptors (see Fig. 9). If there is dimin-
ished acid-induced ligand-receptor dissociation in the acidic
sorting endosome, the normal rapid delivery of dissociated
ligand to perinuclear lysosomes would not occur as com-
pletely as it does with small aVLDL, LDL, or U2M . In-
stead, a substantial portion of the ,QVLDL would possibly
end up in recycling endosomes (like transferrin [5, 21]) or
some other vesicles distal to sorting endosomes. Attempts to
colocalize large ,QVLDL and transferrin have been unsuc-
cessful because of the low amount of uptake of transferrin
in mouse peritoneal macrophages. In addition, we have been
unable to detect significant recycling of internalized /3VLDL
(our unpublished data) . Thus, the actual identity and fate of
the OVLDL-containing vesicles must await further experi-
mentation.
Previous work has indicated that receptor cross-linking
can block ligand-receptor recycling. Hopkins and Trow-
bridge (14) showed that multivalent transferrin on gold parti-
cles was targeted first to multivesicular bodies and then to
lysosomes in human carcinoma A431 cells instead of being
recycled like univalent transferrin. Similarly, Weissman et
al. (38) foundthat exposure ofhumanerythroleukemia K562
cells to a divalent antitransferrin receptor antibody blocked
receptor recycling, perhaps through receptor cross-linking.
Melhnan and Plutner (26) demonstrated that Fc receptors on
J774 cellsand thioglycollate-elicited mouse peritoneal mac-
rophages were recycled when exposed to monovalent ligands
but were delivered to lysosomes when exposed to polyva-
lent IgG complexes. Other receptors whose recycling was
blocked by polyvalent antibodies include the LDL receptor
on human fibroblasts (1), the insulin receptor on IM-9 lym-
phocytes (32), and the cation-independent (215-kD) phos-
phomannosyl receptor on human fibroblasts (29). In several
of the examples above, the multivalent-bound receptors were
targeted to lysosomes. Interestingly, however, the intracellu-
lar distribution ofphosphomannosyl receptors changed from
1558theirnormaljuxtanuclear site to a more peripheral distribu-
tion upon addition ofpolyvalent antibody (29) . The hypothe-
sis put forth here is that LDL receptor cross-linking on
mouse peritoneal macrophages (i.e., by "multivalent" large
aVLDL) changes endocytic targeting on the ligand from a
lysosomal distribution to, at least initially, a more widely
distributed pattern. The explanation of why, in our case,
putative receptor cross-linking leads to a more peripheral
endocytic, and less lysosomal,pattern awaits further investi-
gation into the nature of the (3VLDL-containing vesicles,
the eventual fate of RVLDL in our cells, and the targeting
of lipoproteins such as ,QVLDL in different cell types.
Nonetheless, the possibility that LDL receptor cross-linking
by large OVLDL results in its endocytic divergence from
small ,QVLDL and LDL may represent an important physio-
logical example ofthe effect ofreceptor cross-linking on en-
docytic targeting.
The original impetus for our previous study on the diver-
gent endocytic pathways of,8VLDLand LDL in mouse peri-
toneal macrophages was ahypothesis which attempted to ex-
plain the greater ability of QVLDL to stimulate ACAT in
these cells (37). According to this hypothesis, the targeting
of /3VLDL to a set of vesicles distinct from those of LDL
would lead to a greater stimulation of ACAT by the /3VLDL.
The actual mechanism might involve a physical association
ofthe ,QVLDL-containing vesicles with ACAT (or proximity
to the enzyme). Alternatively, the OVLDL-containing vesi-
cles may possess some property, such as increased ability to
transfer cholesterol, that would lead to increased ACAT
stimulation. Although the current study does not directly ad-
dress these possible mechanisms, the data continue to sup-
port the overall hypothesis linking endocytic targeting with
ACAT stimulation. For instance, large /3VLDLare targeted
in a more widely distributed pattern than small OVLDL (see
Figs. 3 and 4) and also have a higher ACAT stimulatory
potential than the smaller particles (see Fig. 5). Similarly,
the partial anti-Apo E treatment ofaVLDLchanged its tar-
geting to a more central pattern (see Fig. 7) and also de-
creased its ability to stimulate ACAT (see Fig. 8) . Thus, the
study strengthens the correlation between the targeting of
O3VLDL to widely distributed vesicles and high ACAT stim-
ulation and therefore further supports the causal nature of
this relationship.
The widely distributed endocytic pattern and high ACAT
stimulatory potential of large RVLDL may have particu-
lar relevance to our understanding of atherogenesis. Large
O3VLDL, which is intestinally derived, has structural and
metabolic properties similar to those of postprandial chylo-
micron remnants (9), which may be a relatively common
atherogenic particle in man (39). Thus, by studying in detail
the pathways and metabolism of these particles in macro-
phages, the cell type that leads to atheroma foam cells (8, 10,
34), further insight into their association with atherogenesis
may be gained. Although our current hypothesis has focused
on the relationship between the endocytic pathway of these
particles and ACAT stimulation, it is possible that other or
additional consequences of the pathway (e.g., specific pro-
teolytic processingofthe proteins or catabolismofthe lipids
of large /3VLDL) may be revealed and shown to be physio-
logically important.
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